Search 

KIPAX is a private investor specialized into Medtech and was founded 2010.

Investments have been made for instance into SenseAbues (breath based drug testing), Contego (Embolic Protection Devices), AEEG (Cardiac surgical devices), Zoomcamp (vehicle for disabled persons), and others.

We prefer to invest into early phase startup companies as a co-investor, but not a lead investor.

KIPAX is working in close cooperation with KIPA, a Swedish based IP firm specialized into medical devices.

KIPAX is scouting for new investemnt projects and is  this year represented by Erik Krahbichler.

Otivio is a Medtech company with technology which improves blood flow to the limbs of patients. This can be used for treatment of chronic ischemic wounds, in particular for patients with reduced peripheral circulation.

Another application is to exploit the improved blood flow to heat or cool patients by using the the limb as a heat exchanger.

Otivio is a coordinator of an EU funded project and are currently looking for funding to strenghten its organization and fund additional activites.

RemoteA Ltd offers easy-to-use and cost-efficient solutions for simplifying the diagnosis of common medical disorders like cardiac arrhythmias, sleep apnea and hypertension.

Firstly, our browser-based system with state-of-the-art data security enables medical specialist consultation in the first point of care. Health care costs will be substantially reduced as fewer patients will be referred to hospitals; instead they can be diagnosed and treated in the first point of care. Simultaneously, accessibility to care and quality of care are improved.

Secondly, our smart ECG solution enables cardiac arrhythmias testing at home analogically to how blood pressure measurements were shifted from doctors' offices to homes in 1980’s and 1990’s.

Technology is based on the development since 2002.

Synergus is a MedTech Consulting Company in Reimbursement & Health Economics and Quality & Regulatory

Synoste is a Finnish startup company that develops and will sell novel patient friendly medical solutions for treatment of skeletal deformities. The first target is a better device for the well known, but complication prone limb lengthening procedure, which is still extremely uncomfortable for the patient.  Synoste utilizes smart materials and introduces a less painful and precisely controllable treatment device that lowers the complication rate and enables faster recovery to normal life.